Low incidence of invasive fungal infection and risk factors in a large observational cohort of patients initiating TNF-alpha inhibitors for dermatologic conditions

Ian P Hennessee; Kaitlin Benedict; Nathan C Bahr; Shari R Lipner; Jeremy A W Gold

doi:10.1016/j.jaad.2024.03.046

Low incidence of invasive fungal infection and risk factors in a large observational cohort of patients initiating TNF-alpha inhibitors for dermatologic conditions

J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00648-0. doi: 10.1016/j.jaad.2024.03.046. Online ahead of print.

Authors

Ian P Hennessee¹, Kaitlin Benedict², Nathan C Bahr³, Shari R Lipner⁴, Jeremy A W Gold²

Affiliations

¹ Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Electronic address: ihennessee@cdc.gov.
² Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
³ Division of Infectious Diseases, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
⁴ Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.

PMID: 38685411
DOI: 10.1016/j.jaad.2024.03.046

No abstract available

Keywords: Stevens-Johnson syndrome; TNF-alpha inhibitors; biologics; candidiasis; coccidioidomycosis; corticosteroids; esophageal candidiasis; hidradenitis suppurativa; histoplasmosis; invasive fungal infections; psoriasis; pyoderma gangrenosum; seborrheic dermatitis.

Grants and funding

K23 NS110470/NS/NINDS NIH HHS/United States